Money9: During the corona epidemic where crores of people of the country and the world were troubled, it proved to be a big profit opportunity for some pharma companies. One such Indian company Divi’s Laboratories Or Divi’s Lab is In March 2020, when lockdown was imposed in India due to Corona, Divi’s Lab shares were around Rs 3,450. After this, in October 2021, this stock reached 5372 rupees. That is, in about a year and a half, the stock gave investors a whopping 55 percent return… but after October 2021, the stock started moving downhill again. The situation is such that investors have lost more in the stock. than the entire pharma index.
The stock fell 30 percent in 3 months
Despite posting record sales and operating profit in the fourth quarter, Divi’s Lab’s stock has fallen nearly 20 percent over the past 3 months…..while the pharma index has fallen just 11 percent over the period. The company has made a profit of Rs.894 crore in the March quarter. Profit has increased by 78 percent compared to last year. At the same time, the company’s revenue in the fourth quarter rose 40 percent over last year to Rs. 2518 crore has reached the level. Divi’s Labs is a leading developer of APIs.
Finally, what’s happening to Divini Labs stock?
Now the question is what is happening to Divi’s Lab stock? Download Money9’s app by clicking this link to view the full report
https://onelink.to/gjbxhu
What is Money9?
Money9’s OTT app is now available on Google Play and iOS. Everything related to your money happens here in seven languages.. This is a unique experience of its kind. Here are things related to stock market, mutual funds, property, tax, economic policies etc., which affect your pocket on your budget. So what’s the delay, download Money9’s app and increase your financial understanding because Money9 says it’s easy to understand.
. Source